Qualigen Therapeutics, Inc. (QLGN)

Qualigen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	0.09	0.4	3.17	17.54	0.15	1.7
Cash & Cash Equivalents	0.09	0.4	3.17	17.54	0.15	1.7
Cash Growth	-97.87%	-87.31%	-81.95%	11353.86%	-90.99%	-88.51%
Receivables	0	0	0	0.82	0.71	0
Inventory	0	0	0	1.06	0.66	0
Other Current Assets	0.91	0.76	7.65	1.38	0.1	0.51
Total Current Assets	1	1.17	10.82	20.8	1.62	2.21
Property, Plant & Equipment	0	0	0.03	1.85	1.51	0.11
Goodwill and Intangibles	0	0	0	0.17	0.57	0
Other Long-Term Assets	0	0.87	8.24	0.02	0.02	0.48
Total Long-Term Assets	0	0.87	8.26	2.04	2.1	0.59
Total Assets	1	2.03	19.08	22.84	3.72	2.8
Accounts Payable	1.8	2.22	0.62	0.89	1.81	1.42
Deferred Revenue	0	0	0	0.23	0.38	0
Current Debt	1.02	1.3	0.06	0.13	1.91	0.1
Other Current Liabilities	1.7	0.61	7.93	3.39	1.24	0.18
Total Current Liabilities	4.52	4.14	8.61	4.64	5.34	1.7
Long-Term Debt	0	0	0	1.54	0.31	0
Other Long-Term Liabilities	0	0	1.71	0.09	0	0
Total Long-Term Liabilities	0	0	1.71	1.64	0.31	0
Total Liabilities	4.52	4.14	10.32	6.27	5.65	1.7
Total Debt	1.02	1.3	0.06	1.68	2.22	0.1
Debt Growth	-65.93%	2058.27%	-96.41%	-24.44%	2108.66%	-
Retained Earnings	-118.84	-116.8	-103.39	-84.74	-47.3	-80.33
Comprehensive Income	0	0	0.05	0	0	0
Shareholders' Equity	-3.52	-2.1	7.24	16.56	-1.93	1.1
Net Cash / Debt	-0.93	-0.9	3.11	15.86	-2.07	1.6
Net Cash / Debt Growth	-	-	-80.42%	-	-	-89.19%
Net Cash Per Share	-0.16	-0.18	0.81	5.41	-3.69	41.78
Working Capital	-3.52	-2.97	2.21	16.16	-3.72	0.51
Book Value Per Share	-0.59	-0.41	1.88	5.65	-3.44	28.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).